Functional Characterization of the Hepatitis C Virus E1-E2 Glycoproteins
Functional Characterization of the Hepatitis C Virus E1-E2 Glycoproteins
批准号:
7897844
负责人:
Gregory B Melikian
金额:
$3.7万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-22 至 2010-07-31
关键词:
AcidsBindingBiological AssayBiological ModelsCell fusionCell membraneCell surfaceCellsCellular MembraneChimeric ProteinsClathrinEndocytosisEndosomesFailureFluorescence MicroscopyGenus AlpharetrovirusGlycoproteinsHIVHepatitis CHepatitis C virusImageIncubatedIndividualInfectionInfection preventionKineticsLightMeasuresMediatingMembraneMethodologyModelingMonitorNucleocapsidPathway interactionsPrevention strategyProcessRetroviral VectorSiteStagingStressTemperatureTestingTimeVaccinesViralViral Fusion ProteinsViral GenomeVirusVirus InactivationVirus ReceptorsWorkbasebeta-Lactamasedesigneffective therapyinsightnovel virusparticlepathogenpublic health relevancereceptorreceptor bindingresearch studytraffickinguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The hepatitis C virus (HCV) is an important pathogen that has infected approximately 170 million people worldwide. In spite of extensive efforts, surprisingly little is known about the mechanism by which HCV initiates infection. The lack of vaccine or effective therapy against this virus stresses the urgent need for studies of HCV entry into host cells. HCV is an enveloped virus that enters cells via a clathrin-mediated pathway and releases its nucleocapsid by fusing the viral membrane with an endosomal membrane a process that is promoted by HCV E1 and E2 glycoproteins. The fusion induced by E1E2 is strictly receptor- and low pH-dependent. Not only is the mechanism of this process poorly understood, but even the identity of the fusion protein (E1 vs. E2) has not been established. This is due to the lack of a tractable model system to study HCV fusion. Our working hypothesis is that HCV fusion precedes through at least two major steps - a priming step through interactions with cellular receptors which render E1E2 fusogenic, followed by low pH-dependent fusion. This hypothesis predicts that: (1) low pH pre-treatment in the absence of receptors does not induce irreversible conformational changes in E1E2 leading to virus inactivation; (2) binding to soluble or to membrane-anchored receptors renders E1E2 competent to undergo conformational changes and promote fusion at low pH. These predictions will be tested using novel virus inactivation, virus-cell fusion and cell-cell fusion assays. Time-resolved imaging of single virus will be implemented for tracking HCV uptake and subsequent fusion with an endosome. HCV entry will be further examined by capturing and characterizing distinct intermediate stages of fusion. These experiments should provide new insights into the mechanism of E1E2-induced fusion and might help to design preventive strategies to block HCV infection. PUBLIC HEALTH RELEVANCE: Hepatitis C virus (HCV) is an important pathogen that has infected over 170 million people worldwide. Following HCV internalization by a cell, infection is initiated by merging of viral and cellular membranes that releases the viral genome. To elucidate the mechanism of membrane merger mediated by HCV glycoproteins, single virus entry into a host cell will be visualized by real-time by fluorescence microscopy. Understanding the virus entry process will suggest new strategies to prevent infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biophysics Core
-
批准号:10508448
-
项目类别:
-
资助金额:$77.98万
-
财政年份:2022
-
负责人:Gregory B Melikian
-
依托单位:
Biophysics Core
-
批准号:10650878
-
项目类别:
-
资助金额:$80.21万
-
财政年份:2022
-
负责人:Gregory B Melikian
-
依托单位:
Molecular Interactions of HIV-1 with the Nuclear Pore Complex
-
批准号:10241258
-
项目类别:
-
资助金额:$136.92万
-
财政年份:2019
-
负责人:Gregory B Melikian
-
依托单位:
Molecular Interactions of HIV-1 with the Nuclear Pore Complex
-
批准号:10462620
-
项目类别:
-
资助金额:$134.88万
-
财政年份:2019
-
负责人:Gregory B Melikian
-
依托单位:
Inhibition of viral entry by interferon-induced proteins
-
批准号:10418696
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2018
-
负责人:Gregory B Melikian
-
依托单位:
Inhibition of viral entry by interferon-induced proteins
-
批准号:10190798
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2018
-
负责人:Gregory B Melikian
-
依托单位:
Imaging of Single HIV-1 Uncoating and Transport to the nucleus
-
批准号:9354023
-
项目类别:
-
资助金额:$59.65万
-
财政年份:2017
-
负责人:Gregory B Melikian
-
依托单位:
Kinetic Determinants of HIV Neutralization
-
批准号:7929311
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2010
-
负责人:Gregory B Melikian
-
依托单位:
Kinetic Determinants of HIV Neutralization
-
批准号:8142878
-
项目类别:
-
资助金额:$19.18万
-
财政年份:2010
-
负责人:Gregory B Melikian
-
依托单位:
Functional Characterization of the Hepatitis C Virus E1-E2 Glycoproteins
-
批准号:7522862
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2009
-
负责人:Gregory B Melikian
-
依托单位:
Functional Characterization of the Hepatitis C Virus E1-E2 Glycoproteins
-
批准号:8116923
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2009
-
负责人:Gregory B Melikian
-
依托单位:
Entry Mechanisms used by a model retrovirus
-
批准号:7370296
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
The entry mechanism used by a model retrovirus.
-
批准号:7008544
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
The Mechanism of Arenavirus Entry into Cells
-
批准号:10623143
-
项目类别:
-
资助金额:$41.76万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
Entry mechanisms used by a model retrovirus
-
批准号:8577613
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
Entry mechanisms used by a model retrovirus
-
批准号:8656664
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
The Mechanism of Arenavirus Entry into Cells
-
批准号:9889875
-
项目类别:
-
资助金额:$41.76万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
The Mechanism of Arenavirus Entry into Cells
-
批准号:9755767
-
项目类别:
-
资助金额:$44.56万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
The entry mechanism used by a model retrovirus.
-
批准号:7176092
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
Entry Mechanisms used by a model retrovirus
-
批准号:8116813
-
项目类别:
-
资助金额:$38.29万
-
财政年份:2003
-
负责人:Gregory B Melikian
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: